AGIOS PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $345.1M | $71.8M |
| FY2016 | — | $358.6M | $160.8M |
| FY2017 | — | $375.5M | $102.7M |
| FY2018 | — | $687.5M | $70.5M |
| FY2019 | — | $640.5M | $80.9M |
| FY2020 | — | $399.5M | $127.4M |
| FY2021 | — | $1.29B | $203.1M |
| FY2022 | — | $1.10B | $139.3M |
| FY2023 | — | $811.0M | $88.2M |
| FY2024 | — | $1.54B | $76.2M |